https://www.selleckchem.com/products/k-975.html
0142). There was no significant difference in POV among the three groups. PAED or EA scores among the three groups were similar during recovery time. CONCLUSION Dexmedetomidine (0.5 μg/kg) reduced OCR and PONV without lengthening extubation time or recovery time in pediatric patients undergoing strabismus surgery. TRIAL REGISTRATION The trial was prospectively registered before patient enrollment at Chinese Clinical Trial Registry (Clinical Trial Number ChiCTR1800020176, Date 12/19/2018).BACKGROUND A large number of in vitro experiments h
Curtir
Comentario
Compartilhar
